VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO Breast 2020 | Endocrine therapy in premenopausal women with HR+ breast cancer

Michael Gnant, MD, Vienna General Hospital, Vienna, Austria, discusses the management of endocrine therapy in premenopausal women with hormone receptor-positive (HR+) breast cancer. Prof. Gnant outlines the most common side effects of endocrine therapy. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter